3Ploeg RJ, D'Alessandro AM,Knechtle SJ, et al.Risk factors for primary dysfunction after liver transplantation-Multivariate analysis[J].Transplantation,1993,55(4):807-813.
4Orozco H, Mercado MA, Chan C,et al. Current role of surgery for the treatment of portal hypertension[J]. Ann Hepal,2002,1(4):175-178.
5Merli M,Salerno F,Riggio O,et al.Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis:a randomized multicenter trial[J].Hepatology,1998,27(1):48-53.
6Raia S,da Silva LC,Gayctto LC,et al.A long-time follow-up of a randomized trial comparing three type of surgery[J].Hepatology,1994,20(2):398-403.
7Hillert C, Fischer L, Broering DC,et al.Liver transplantation in patients with liver cirrhosis and esophageal bleeding[J]. Langenbecks Arch Surg, 2003,388(3):150-154.
8Orug T, Soonawalla ZF, Tekin K, et al.Role of surgical portosystemic shunts in the era of interventional radiology and liver transplantation[J]. Br J Surg,2004, 91(6):769-773.
9Ben Hamida C,Lauzet JY,Rezaiguia-Delclaux S,et al. Effect of severe thrombocytopenia on patient outcome after liver transplantation[J]. Intensive Care Med, 2003 ,29(5):756-762.
10McCaughan GW, Herkes R, Powers B,et al. Thrombocytopenia post liver transplantation. Correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome[J]. J Hepatol, 1992 ,16(1-2):16-22.
